|
Pharmacological Group: Antineoplastics, Active Ingredient: Cisplatin, Pharmaceutical Form: Injectable Solution, Concentration / Dosage: 1, Unit: Mg/Ml, Volume: 50Ml, Presentation: Ampoule Vial, Accessory: Not Applicable, Active Ingredient: Cytarabine, Concentration / Dosage: 500 Mg, Volume: 5 Ml, Presentation: Ampoule Bottle, Accessory: N/A, Active Ingredient: Dacarbazine, Pharmaceutical Form: Injectable Lyophilic Powder, Concentration / Dosage: 200, Unit: Mg, Volume: Not Applicable, Pharmacological Group: Antineoplastic, Active Ingredient: Degarelix, Acetate, Pharmaceutical Form: Lyophilized Powder, Concentration / Dosage: 80, Volume: 6 Ml, Accessory: Diluent 6 Ml, Active Ingredient: Etoposide, Concentration / Dosage: 20, Volume: 5Ml, Active Ingredient: Melphalan, Pharmaceutical Form: Coated Tablet, Concentration / Dosage: 2, Presentation: Not Applicable, Pharmacological Group: Antineoplastic - Antimetabolites, Principle Active: Melphalan, Concentration / Dosage: 50, Unit: Mg, Presentation: Bottle, Active Ingredient: Methotrexate, Pharmaceutical Form: Tablet, 5, Active Ingredient: Transretinoic Acid - Tretinoin, Pharmaceutical Form: Capsule, Concentration / Dosage: 10, Volume: N/A, Presentation: N/A
|
